Stratta R J, Larsen J L, Cushing K
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280, USA.
Annu Rev Med. 1995;46:281-98. doi: 10.1146/annurev.med.46.1.281.
Vascularized pancreas transplantation has assumed an increasing role in the treatment of diabetes mellitus. Through 1993, over 5500 pancreas transplants have been performed worldwide, with over 80% being combined pancreas-kidney transplants. Overall one-year patient survival exceeds 90% and graft survival (complete insulin independence) exceeds 70%. Although successful pancreas transplantation achieves euglycemia and complete insulin independence, this occurs at the expense of hyperinsulinemia and chronic immunosuppression. The net result of these changes on diabetic complications in the long term remains to be determined. In the short term, improvement in the quality of life and possible prevention of further morbidity associated with diabetes makes pancreas transplantation an important therapeutic option, particularly when combined with a kidney transplant, in appropriately selected diabetic patients.
血管化胰腺移植在糖尿病治疗中发挥着越来越重要的作用。截至1993年,全球已进行了超过5500例胰腺移植,其中超过80%是胰肾联合移植。总体而言,患者一年生存率超过90%,移植胰腺的存活(完全不依赖胰岛素)率超过70%。尽管成功的胰腺移植能够实现血糖正常和完全不依赖胰岛素,但这是以高胰岛素血症和长期免疫抑制为代价的。这些变化对糖尿病并发症的长期净影响仍有待确定。短期内,生活质量的改善以及可能预防与糖尿病相关的进一步发病,使得胰腺移植成为一种重要的治疗选择,特别是在适当选择的糖尿病患者中与肾移植联合进行时。